Long-term Follow-up of Living Liver Donors: A Single-center Experience
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Mansoura University
- Enrollment
- 476
- Primary Endpoint
- health-related quality of life (HRQoL)
Study Overview
Brief Summary
Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.
Detailed Description
Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.
We used the 36-item short-form health survey (short form-36 health survey, version 1 [SF-36]). The scores for the 4 following subscales were higher in nondonors than in donors: physical functioning (P = 0.009), role limitations due to physical health (P = 0.002), energy/fatigue (P < 0.001), and bodily pain (P < 0.001). The scores on the 8 subscales of the SF-36 were higher in donors with living recipients than in donors whose recipients died (P < 0.001). Our results suggest that living donor right hepatectomy is safe and results in a postdonation HRQoL similar to that of nondonors in those donors whose recipients are healthy, while donors whose recipients die have a lower HRQoL that is significantly negatively correlated with the time since recipient death and improves over time.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •age 18-50 years
- •no comorbidities.
- •BMI less than 30 kg/m
- •compatible ABO group.
Exclusion Criteria
- •Older than 50 years.
- •Associated comorbidities.
- •Noncompatible ABO group.
Outcomes
Primary Outcomes
health-related quality of life (HRQoL)
Time Frame: 4 to 16 years of follow up
health-related quality of life (HRQoL) (36-item short-form health survey, version 1 \[SF-36\]).
Secondary Outcomes
No secondary outcomes reported
Investigators
Ahmed Shehta
MD, PhD
Mansoura University
